Comparing the effect of botulinum toxin type B injection at different dosages for patient with drooling due to brain lesion

Annals of Rehabilitation Medicine

Volumn 36, Issue 6, 2012, Pages 841-848

  Park, Hee Dong ^a   Kim, Hyo Jae ^a   Park, Sang Jun ^a   Choi, Yong Min ^a  

^a Seoul Medical Center   (South Korea)

Author keywords

Botulinum toxin; Brain lesion; Drooling; Submandibular gland; Ultrasound

Indexed keywords

EID: 84872570627     PISSN: 22340645     EISSN: 22340653     Source Type: Journal    
DOI: 10.5535/arm.2012.36.6.841     Document Type: Article

References (20)

1. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physi- cian 2004; 69: 2628-2634
2. Hussein I, Kershaw AE, Tahmassebi JF, Fayle SA. The management of drooling in children and patient with mental and physical disablities: a literature review. Int J Pediartr Dent 1998; 8: 3-11
3. Proulx M, de Courval FP, Wiseman MA, Panisset M. Salivary production in Parkinson's disease. Mov Disord 2005; 20: 204-207
4. Giess R, Naumann M, Werner E, Riemann R, Beck M, Puls I, Reiners C, Toyka KV. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis. J Neurol Neurosurg Psy-chiatry 2000; 69: 121-123
5. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002; 112: 73-81
6. Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for si-alorrhoea in children with cerebral palsy. Dev Med Child Neurol 2006; 48: 883-887
7. Mankarious LA, Bottrill ID, Huchzermyer PM, Bailey CM. Long-term follow-up of submandibular duct re-routing for the treatment of sialorrhea in the pediatric population. Otolaryngol Head Neck Surg 1999; 120: 303-307
8. Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, et al. Safery and efficacy of NeuroBlock (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999; 53: 1431-1438
9. Bushara KO. Sialorrhea in amyotrophic lateral sclero-sis: a hypothesis of a new treatment - botulinum toxin A injections of the parotid glands. Med Hypotheses 1997; 48: 337-339
10. Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling. J Neurol 2009; 256: 563-567
11. Ondo WG, Hunder C, Moore W. A double-blind place-bo-controlled trial of botulium toxin B for sialorrhea in Parkinson's diease. Neurology 2004; 62: 37-40
12. Enfors BO. The parotid and submandibular secretion in man. Quantitative recordings of the normal and pathological activity. Acta Otolaryngol Suppl 1962; 172: 1-67
13. Jongerius PH, van Hulst K, vanden Hoogen FJ, Rot-teveel JJ. The treatment of posterior drooling by botu- linum toxin in a child with cerebral palsy. J Pediatr Gastroenterol Nutr 2005; 41: 351-353
14. Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for si-alorrhoea in children with cerebral palsy. Dev Med Child Neurol 2006; 48: 883-887
15. Freed ML, Freed L, Chatburn RL, Christian M. Electrical stimulation for swallowing disorders caused by stroke. Respir Care 2001; 46: 466-474
16. Kim H, Lee Y, Weiner D, Kaye R, Cahill AM, Yudkoff M. Botulinum toxin type A injection to salivary glands: combination with single event multilevel chemoin-eirolysis in 2 children with severe spastic qudriplegic cerebral palsy. Arch Phys Med Rehabil 2006; 87: 141-144
17. Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Consortium on drooling. Dev Med Child Neurol 1992; 34: 849-862
18. Bae HS, Park CI, Rha DW, Nam HS, Vaq SG, Min KH, Park JB. Factors affecting drooling in adult patients with traumatic brain injury. J Korean Acad Rehab Med 2006; 30: 424-429
19. Jongerius PH, Joosten F, Hoogen FJ, Gabreels, FJ, Rot-teveel JJ. The treatment of drooling by ultrasound-quided intraglandular injections of botulinum toxin type A into the salivary glands. Laryngoscope 2003; 113: 107-111
20. Dressler D, Adib Saberi F, Benecke R. Botulinum toxin type B for treatment of axillar hyperhidrosis. J neurol 2002; 249: 1729-1732